Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Browse by Journal Title

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type
Jump to: 2012 | 2003 | 1995 | 1991

2012

Rationale and design of the prevention of cardiac dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial.
Heck, S.L. and Gulati, G. and Ree, A.H. and Schulz-Menger, J. and Gravdehaug, B. and Rosjo, H. and Steine, K. and Bratland, A. and Hoffmann, P. and Geisler, J. and Omland, T.
Cardiology 123 (4): 240-247. 30 November 2012

2003

Rosuvastatin - A highly effective new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor: Review of clinical trial data at 10-40 mg doses in dyslipidemic patients.
Schuster, H.
Cardiology 99 (3): 126-139. June 2003

1995

Local renin-angiotensin systems in cardiovascular tissues: localization and functional role.
Stock, P. and Liefeld, L. and Paul, M. and Ganten, D.
Cardiology 86 (Suppl.1): 2-8. 1 January 1995

1991

Tissue renin-angiotensin systems and their modulation: the heart as a paradigm for new aspects of converting enzyme inhibition.
Lindpaintner, K. and Ganten, D.
Cardiology 79 (Suppl 1): 32-44. 1 January 1991

This list was generated on Thu Oct 18 02:32:06 2018 CEST.
Open Access
MDC Library